Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test
Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform
Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk
